Christopher Krawtschuk

Christopher Krawtschuk

Director of Finance/CFO at BLUEBIRD BIO, INC.

Net worth: 58 207 $ as of 2024-03-30

51 year
Health Technology
Commercial Services
Consumer Services

Profile

Christopher Stanley Krawtschuk is currently the Director at Draximage UK Ltd.
and the Chief Financial Officer at bluebird bio, Inc. Previously, he held positions as the Managing Director at PricewaterhouseCoopers International Ltd., VP-Lead Divisional Controller at Pfizer Inc., and Chief Financial Officer at Jubilant Pharma Holdings, Inc. He completed his undergraduate degree at William Paterson University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-29 45,474 ( 0.02% ) 58 207 $ 2024-03-30

Christopher Krawtschuk active positions

CompaniesPositionStart
BLUEBIRD BIO, INC. Director of Finance/CFO 2022-11-06
Director/Board Member 2021-03-02
All active positions of Christopher Krawtschuk

Former positions of Christopher Krawtschuk

CompaniesPositionEnd
PFIZER, INC. Comptroller/Controller/Auditor -
Corporate Officer/Principal -
Jubilant Pharma Holdings, Inc. Chief Operating Officer -
See the detail of Christopher Krawtschuk's experience

Training of Christopher Krawtschuk

William Paterson University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Krawtschuk's experience

Connections

21

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PFIZER, INC.

Health Technology

BLUEBIRD BIO, INC.

Health Technology

Private companies3

Commercial Services

Commercial Services

Jubilant Pharma Holdings, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Krawtschuk